Remicade

infliximab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

153 regulatory and trial events tracked for Remicade, covering 2007-02-27 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis [Phase 3]